-+ 0.00%
-+ 0.00%
-+ 0.00%

ALX Oncology shareholders ratify KPMG as auditor for 2026 fiscal year

PUBT·06/11/2026 20:02:57
Listen to the news
ALX Oncology shareholders ratify KPMG as auditor for 2026 fiscal year
  • ALX Oncology Holdings held its annual shareholder meeting on June 10, 2026.
  • Shareholders backed the selection of two Class II directors, with the terms running to the 2029 annual meeting.
  • Shareholders ratified KPMG LLP as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ALX Oncology Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-267472), on June 11, 2026, and is solely responsible for the information contained therein.